Léonard Kollros

Corneal biomechanics ran through ELZA’s Saturday in London, from a didactic course talk to data showing that more than 30% of the children of keratoconus patients already have measurable corneal abnormalities.
Vitamin B2 tablets and sunshine. Hard lenses that hold the cone back. A cornea too thin to treat. Seven things patients are commonly told about keratoconus, checked against the Second Global Consensus, in which 128 corneal experts from six continents voted on what the evidence actually supports.
The ELZA Institute travels to the 44th ESCRS Congress at ExCeL London, 11 to 15 September 2026, with seven podium presentations, nine invited lectures, six chaired sessions and six e-posters. The programme spans ten-year cross-linking outcomes, customised ELZA-PACE, ECO-CAIRS ring segments and keratoconus screening.
ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
The ELZA team presented at OPT-X.25 in Baden, showcasing our Zurich keratoconus treatment expertise from diagnostics and contact lenses to advanced surgical care
Highlights from ESCRS 2025 ELZA Institute Sunday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
Highlights from ESCRS 2025 ELZA Institute Sunday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
Highlights from ESCRS 2025 ELZA Institute Friday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
Highlights from ESCRS 2025 ELZA Institute Saturday sessions in Copenhagen, featuring advances in keratoconus, glaucoma, and corneal surgery
From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…
.
.